|
1.
|
JJ SungJY LauKL GohWK Leungthe Asia
Pacific Working Group on Colorectal CancerIncreasing incidence of
colorectal cancer in Asia: implications for screeningLancet
Oncol11871876200510.1016/S1470-2045(05)70422-816257795
|
|
2.
|
E JullumstrøA WibeS LydersenTH EdnaColon
cancer incidence, presentation, treatment and outcomes over 25
yearsColorectal Dis13512518201120128833
|
|
3.
|
PP BoyleJS LangmanABC of colorectal
cancer:
epidemiologyBMJ321805808200010.1136/bmj.321.7264.80511009523
|
|
4.
|
NS FearnheadJL WildingWF BodmerGenetics of
colorectal cancer: hereditary aspects and overview of colorectal
tumorigenesisBr Med Bull642743200210.1093/bmb/64.1.2712421723
|
|
5.
|
W DuWY LiR LuJY FangFolate and fiber in
the prevention of colorectal cancer: between shadows and the
lightWorld J
Gastroenterol16921926201010.3748/wjg.v16.i8.92120180229
|
|
6.
|
M BordonaroDL LazarovaAC
SartorelliButyrate and Wnt signaling: a possible solution to the
puzzle of dietary fiber and colon cancer risk?Cell
Cycle711781183200810.4161/cc.7.9.581818418037
|
|
7.
|
P MarksRA RifkindVM RichonR BreslowT
MillerWK KellyHistone deacetylases and cancer: causes and
therapiesNat Rev Cancer1194202200110.1038/3510607911902574
|
|
8.
|
PT MeinkeP LiberatorHistone deacetylase: a
target for antiproliferative and antiprotozoal agentsCurr Med
Chem8211235200110.2174/092986701337378711172676
|
|
9.
|
UH WeidleA GrossmannInhibition of histone
deacetylases: a new strategy to target epigenetic modifications for
anticancer treatmentAnticancer Res2014711485200010928059
|
|
10.
|
EI BukreevaND AksenovAA BardinVA
PospelovTV PospelovaEffect of histone deacetylase inhibitor sodium
butyrate (NaB) on transformants E1a + cHa-Ras expressing wild-type
p53 with suppressed transactivation
functionTsitologiia516977052009(In Russian)
|
|
11.
|
H UchidaT MaruyamaT AraseM OnoT NagashimaH
MasudaH AsadaY YoshimuraHistone acetylation in reproductive organs:
significance of histone deacetylase inhibitors in gene
transcriptionReprod Med
Biol4115122200510.1111/j.1447-0578.2005.00101.x
|
|
12.
|
H CedarY BergmanLinking DNA methylation
and histone modification: patterns and paradigmsNat Rev
Genet10295304200910.1038/nrg254019308066
|
|
13.
|
L Bouchier-HayesSJ MartinCARD games in
apoptosis and immunityEMBO
Rep3616621200210.1093/embo-reports/kvf13912101092
|
|
14.
|
AR StoneW BoboDJ BratNS DeviEG Van MeirPM
VertinoAberrant methylation and down-regulation of TMS1/ASC in
human glioblastomaAm J
Pathol16511511161200410.1016/S0002-9440(10)63376-715466382
|
|
15.
|
A VirmaniA RathiK SugioUG SathyanarayanaS
ToyookaFC KischelV TonkA PadarT TakahashiJA RothAberrant
methylation of TMS1 in small-cell, non-small cell lung cancer and
breast cancerInt J Cancer106198204200310.1002/ijc.1120612800194
|
|
16.
|
MT McCabeJC BrandesPM VertinoCancer DNA
methylation: molecular mechanisms and clinical implicationsClin
Cancer Res1539273937200910.1158/1078-0432.CCR-08-278419509173
|
|
17.
|
AJ WilsonDS ByunN PopovaLB MurrayK
L’ItalienY SowaD ArangoA VelcichLH AugenlichtJM MariadasonHistone
deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell
maturation and p21 expression and are deregulated in human colon
cancerJ Biol
Chem2811354813558200610.1074/jbc.M51002320016533812
|
|
18.
|
BB McConnellPM VertinoTMS1/ASC: the cancer
connectionApoptosis9518200410.1023/B:APPT.0000012117.32430.0c14739594
|
|
19.
|
M KarinY CaoFR GretenZW LiNF-kappaB in
cancer: from innocent bystander to major culpritNat Rev
Cancer2301310200210.1038/nrc78012001991
|
|
20.
|
JN OuJ TorrisaniA UnterbergerN ProvençalK
ShikimiM KarimiTJ EkströmM SzyfHistone deacetylase inhibitor
Trichostatin A induces global and gene-specific DNA demethylation
in human cancer cell linesBiochem
Pharmacol7312971307200710.1016/j.bcp.2006.12.03217276411
|
|
21.
|
MF FragaE UriolL Borja DiegoM BerdascoM
EstellerMJ CañalR RodríguezHigh-performance capillary
electrophoretic method for the quantification of
5-methyl-2′-deoxycytidine in genomic DNA: application to plant,
animal and human cancer tissuesElectrophoresis23167716812002
|
|
22.
|
SB BaylinM EstellerMR RountreeKE BachmanK
SchuebelJG HermanAberrant patterns of DNA methylation, chromation
and gene expression in cancerHum Mol
Genet10687692200110.1093/hmg/10.7.68711257100
|
|
23.
|
M ZhouP LiL TanS QuQL YingH
SongDifferentiation of mouse embryonic stem cells into hepatocytes
induced by a combination of cytokines and sodium butyrateJ Cell
Biochem109606614201010.1002/jcb.2244220039312
|
|
24.
|
M RenL YanCZ ShangJ CaoLH LuJ MinH
ChengEffects of sodium butyrate on the differentiation of
pancreatic and hepatic progenitor cells from mouse embryonic stem
cellsJ Cell Biochem109236244201019911386
|
|
25.
|
M BartelsCR GeestM BieringsM BuitenhuisPJ
CofferHistone deacetylase inhibition modulates cell fate decisions
during myeloid
differentiationHaematology9510521060201010.3324/haematol.2009.00887020107159
|
|
26.
|
PA MarksVM RichonRA RifkindHistone
deacetylase inhibitors: inducers of differentiation or apoptosis of
transformed cellsJ Natl Cancer
Inst9212101216200010.1093/jnci/92.15.121010922406
|
|
27.
|
R PiekarzS BatesA review of depsipeptide
and other histone deacetylase inhibitors in clinical trialsCurr
Pharm Des1022892298200410.2174/138161204338398015279609
|
|
28.
|
HJ ChoSY KimKH KimWK KangJI KimST OhJS
KimCH AnThe combination effect of sodium butyrate and
5-Aza-2′-deoxycytidine on radiosensitivity in RKO colorectal cancer
and MCF-7 breast cancer cell linesWorld J Surg
Oncol749200919460134
|
|
29.
|
L PanAF MatloobJ DuH PanZ DongJ ZhaoY
FengY ZhongB HuangJ LuVitamin D stimulates apoptosis in gastric
cancer cells in synergy with trichostatin A/sodium butyrate-induced
and 5-aza-2′-deoxycytidine-induced PTEN upregulationFEBS
J277989999201020089040
|
|
30.
|
MA CayoAK CayoSM JarjourH ChenSodium
butyrate activates Notch1 signaling, reduces tumor markers and
induces cell cycle arrest and apoptosis in pheochromocytomaAm J
Transl Res1178183200919956429
|
|
31.
|
K KüsterC GrötzingerA KoschelA FischerB
WiedenmannM AndersSodium butyrate increases expression of the
coxsackie and adenovirus receptor in colon cancer cellsCancer
Invest28268274201019863349
|
|
32.
|
L WangHS LuoH XiaSodium butyrate induces
human colon carcinoma HT-29 cell apoptosis through a mitochondrial
pathwayJ Int Med
Res37803811200910.1177/14732300090370032319589263
|
|
33.
|
BG HeerdtMA HoustonGM AnthonyLH
AugenlichtInitiation of growth arrest and apoptosis of MCF-7
mammary carcinoma cells by tributyrin, a triglyceride analogue of
the short-chain fatty acid butyrate, is associated with
mitochondrial activityCancer Res59158415911999
|
|
34.
|
L YanX YangNE DavidsonRole of DNA
methylation and histone acetylation in steroid receptor expression
in breast cancerJ Mammary Gland Biol
Neoplasia6183192200110.1023/A:101130870751211501578
|
|
35.
|
RJ FerranteJK KubilusJ LeeH RyuA BeesenB
ZuckerK SmithNW KowallRR RatanR Luthi-CarterSM HerschHistone
deacetylase inhibition by sodium butyrate chemotherapy ameliorates
the neurodegenerative phenotype in Huntington’s disease miceJ
Neurosci2394189427200314561870
|
|
36.
|
V ChopinRA ToillonN JouyX Le
BourhisP21waf1/cip1 is dispensable for G1 arrest, but indispensable
for apoptosis induced by sodium butyrate in MCF-7 breast cancer
cellsOncogene232129200410.1038/sj.onc.120702014712207
|
|
37.
|
K FukasawaP53, cyclin-dependent kinase and
abnormal amplification of centrosomesBiochim Biophys
Acta17861523200818472015
|
|
38.
|
SY ArcherJ JohnsonHJ KimQ MaH MouV
DaesetyS MengRA HodinThe histone deacetylase inhibitor butyrate
downregulates cyclin B1 gene expression via a p21/WAF-1-dependent
mechanism in human colon cancer cellsAm J Physiol Gastrointest
Liver Physiol289G696G7032005
|
|
39.
|
X YangDL PhillipsAT FergusonWG NelsonJG
HermanNE DavidsonSynergistic activation of functional estrogen
receptor (ER)-alpha by DNA methyltransferase and histone
deacetylase inhibition in human ER-alpha-negative breast cancer
cellsCancer Res61702570292001
|
|
40.
|
R NimmanapalliE O’BryanM HuangP BaliPK
BurnetteT LoughranJ TepperbergR JoveK BhallaMolecular
characterization and sensitivity of STI-571 (imatinib mesylate,
Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to
SRC kinase inhibitor PD180970 and
17-allylamino-17-demethoxygeldanamycinCancer Res62576157692002
|
|
41.
|
T HeinzelOH KrämerPharmacodynamic markers
for histone deacetylase inhibitor developmentDrug Discov Today Dis
Mech4277283200710.1016/j.ddmec.2008.06.003
|
|
42.
|
K YamaguchiA LantowskiAJ DannenbergK
SubbaramaiahHistone deacetylase inhibitors suppress the induction
of c-Jun and its target genes including COX-2J Biol
Chem2803256932577200510.1074/jbc.M50320120015994313
|
